InflammX’s pipeline includes an orally dosed therapeutic candidate targeting intermediate age-related macular degeneration ...
Bausch + Lomb acquired Whitecap Biosciences, including its two therapies for potential use in glaucoma and geographic atrophy ...
Capping ten years of work to stem the tide of nearsightedness, David Berntsen, Golden-Golden Professor of Optometry and chair ...
We recently compiled a list of the Best Medical Stocks To Buy Under $20. In this article, we are going to take a look at ...
Americans wear contact lenses and 80% of them agree that contacts make them feel more like themselves, are you offering them the latest and greatest?
'ZDNET Recommends': What exactly does it mean? ZDNET's recommendations are based on many hours of testing, research, and comparison shopping. We gather data from the best available sources ...
Evercore ISI lowered the firm’s price target on Bausch + Lomb (BLCO) to $22 from $25 and keeps an Outperform rating on the shares. In the firm’s 2025 outlook note for MedTech, Life Science ...
Ultra by Bausch and Lomb Silicone lenses have not been found to reduce the risk of bacterial keratitis for contact lens wearers. Current research suggests that contact lens-related infections may be ...
Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...
The latest to offer details on the Galaxy S25, S25+ and S25 Ultra is dbrand. The Canadian-based company makes cases and skins for a wide range of consumer electronics. It’s best known for a wide ...
The smart contact lenses market is set for remarkable growth, revolutionizing healthcare and technology with the integration of advanced sensors, displays, and connectivity systems. As wearable ...
Pale colorways are nothing new in the mobile world, but Samsung seems ready to be taking paleness to a whole new level with the upcoming Galaxy S25 Ultra. Today the "blue" colorway for the device ...